Publication | Open Access
Atorvastatin inhibits osteoclast differentiation by suppressing NF-κB and MAPK signaling during IL-1β-induced osteoclastogenesis
21
Citations
31
References
2017
Year
Atorvastatin is a strong inhibitor of inflammation-induced osteoclastogenesis in inflammatory joint diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1